
Inclusion & Culture | Regeneron
The Regeneron Way represents the values and behaviors that define who we are, what we stand for and how we work together. Science drives our business and passion drives our science. …
Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Ethics & Integrity | Regeneron
Delivering medicines to patients in a timely fashion relies on our ability to source the goods and services we need, while meeting specified standards in a sustainable, ethical and cost …
Explore your passion. Work at your best. Change lives. - Regeneron …
The Regeneron Way. Our culture is the formula for our success. These core values aren’t just a series of slogans but behaviors woven into the day-to-day experience of our unique community.
Regeneron 2021 Year In Review | Company Values
the regeneron way Through a year of immense growth, our Regeneron team worked together to maintain our culture of scientific curiosity. By the end of 2021, we had 10,368 full-time …
THE REGENERON WAY Science drives our business and passion drives our science. Whether you’re doing science, supporting science or delivering science. It’s what we do. We take the …
Regeneron Mission, Benefits, and Work Culture | Indeed.com
The Regeneron Way represents our company’s values and behaviors, defines who we are, what we stand for and how we work together. These principles put into words our culture that has …
Regeneron Pharmaceuticals - Wikipedia
Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker. VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a …
Leading with science at Regeneron turns promise to reality for …
Aug 1, 2022 · The Regeneron Way defines who we are, how we work and our ability to achieve the extraordinary for patients. One of the core values of the Regeneron Way is "Lead with …
Paid Program: The Science of Questioning Everything
Challenging everything led to Regeneron’s gamble in the 1990s to identify new foundational technologies for developing biologics medications and, later, new technologies for genetics …